Ischemic Stroke (Lenticulostriate Artery)

Overview


Plain-Language Overview

Ischemic Stroke (Lenticulostriate Artery) occurs when blood flow to a small deep part of the brain is blocked, causing brain cells to die. This condition affects the brain's motor and sensory pathways, leading to sudden weakness or numbness on one side of the body. The lenticulostriate arteries supply important areas involved in movement and sensation, so damage here can cause significant problems with coordination and muscle control. Symptoms often appear suddenly and may include difficulty speaking or understanding speech. This type of stroke is a serious medical emergency that impacts the nervous system and requires prompt diagnosis and treatment to reduce long-term disability.

Clinical Definition

Ischemic Stroke (Lenticulostriate Artery) is a subtype of lacunar stroke caused by occlusion of the small penetrating lenticulostriate arteries, which branch from the middle cerebral artery. The core pathology involves small vessel disease leading to ischemia and infarction in the basal ganglia, internal capsule, or adjacent deep brain structures. The usual mechanism is lipohyalinosis or microatheroma formation secondary to chronic hypertension or diabetes mellitus. Clinically, it presents with pure motor hemiparesis, pure sensory stroke, or sensorimotor deficits without cortical signs. This stroke subtype is significant due to its association with small vessel ischemic disease and risk of recurrent strokes. Imaging typically shows small, deep infarcts without cortical involvement.

Inciting Event

Locked content.

Latency Period

Locked content.

Diagnostic Delay

Locked content.

Clinical Presentation


Signs & Symptoms

Locked content.

History of Present Illness

Locked content.

Past Medical History

Locked content.

Family History

Locked content.

Physical Exam Findings

Locked content.

Diagnostic Workup


Diagnostic Criteria

Locked content.

Pathophysiology


Key Mechanisms

Locked content.

Organs

Locked content.

Tissues

Locked content.

Cells

Locked content.

Chemical Mediators

Locked content.

Treatments


Pharmacological Treatments

Locked content.

Non-pharmacological Treatments

Locked content.

Prevention


Pharmacological Prevention

Locked content.

Non-pharmacological Prevention

Locked content.

Outcome & Complications


Complications

Locked content.

Short-term Sequelae

Locked content.

Long-term Sequelae

Locked content.

Differential Diagnoses


Differentials

Locked content.

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site's content were generated or assisted by AI. All material has been reviewed by Erik Romano, MD, however, errors or omissions may still occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. “USMLE Step 1” and “USMLE Step 2 CK” are used only to identify the relevant examinations.